Top 10 Cancer Drugs Market To Hit Big Revenues (At A a CAGR of 9.8%)

Allied Market Research published a report, titled, "Top 10 Cancer Drugs Market by Region (Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2018–2026." According to the report, the global top 10 cancer drugs industry generated $63.61 billion in 2018, and is estimated to reach $129.94 billion by 2026, witnessing a CAGR of 9.8% from 2019 to 2026.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6225

Drivers, restraints, and opportunities
Surge in incidence of cancer across the globe, increase in aging population, and rise in expenditure of government on healthcare infrastructure drive the global top 10 cancer drugs market. However, adverse effects related to usage of cancer usage hinder the market growth. Contrarily, surge in number of pipeline drugs and untapped potential in emerging geographies create new opportunities in the market.

Drugs such as Revlimid, Opdivo, Keytruda, Herceptin, Avastin, Rituxan, Imbruvica, Neulasta/Peglasta, Ibrance, and Zytiga are the top selling drugs in 2018. The key drivers of the global cancer drugs market are increase in incidence of cancer, rise in adoption of advance therapies such as biological & targeted drug therapies, surge in geriatric population, and rise in collaborations & partnerships to facilitate drug development. In addition, availability of the drugs and increase in healthcare expenditure have significantly contributed toward the growth of this market. Increase in number of pipeline drugs along with high potential of emerging economies are further expected to provide lucrative opportunities for market expansion. However, high cost involved in new drug development and adverse effects related to cancer drugs are expected to impede the market growth.



Leading market players:

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
The global top 10 cancer drugs sales is segmented on the basis of region. Regionally, the market is studied across Europe (Russia, Netherlands, Switzerland, Sweden, Belgium, Austria, Norway, Denmark, Poland, Finland, Portugal, Greece, Ireland, Czech Republic, Hungary, Romania, Ukraine), Asia-Pacific (Taiwan, Indonesia, New Zealand, Singapore, Malaysia, Vietnam, Myanmar, Sri Lanka, Macau, Nepal), and LAMEA (Turkey, Venezuela, Colombia, Argentina, Iran, Israel, Chile, Algeria, United Arab Emirates, Puerto Rico, Morocco, Costa Rica, Lebanon).

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Comments

Post a Comment

Popular posts from this blog

Cell Culture Market Grows as Biotechnology Companies Invest Heavily in Drug Development | CAGR of 10.9%

Image
Allied Market Research recently said “ Cell Culture Market  by Product, Application, and End User: Opportunity Analysis and Industry Forecast, 2020–2027 ," the global cell culture market accounted for $16,107.7 million in 2019, and is expected to reach $36,926.80 million by 2027, registering a CAGR of 10.9% from 2020 to 2027. Increased awareness of the use of cell culture and research and financial growth related to research and growth in cancer-related research are major global cell culture market trends. ♦ 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 - https://www.alliedmarketresearch.com/request-sample/3569 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗜𝗺𝗽𝗮𝗰𝘁 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 (𝗣𝗿𝗲 & 𝗣𝗼𝘀𝘁) - The Covid-19 outbreak has increased the demand for cell culture products to understand the disease and develop therapeutic interventions. Moreover, cell culture offers an opportunity to understand lung disease mechanisms at a cellular level and target pathogenic processes. This h...
Read more

Sleep Aids Market to Reach $111.92 Billion by 2030 | Enhancing Well-Being with Better Sleep

Image
Sleep aids are substances or methods used to help people fall asleep and stay asleep. They are commonly used to treat sleep disorders such as insomnia or to help with temporary sleep problems due to stress, jet lag, or other factors. the  sleep aids market  generated $59.8 billion in 2020, and is projected to reach $111.9 billion by 2030, witnessing a CAGR of 6.9% from 2021 to 2030. Examples of sleep aids include: Medications: Prescription sleep medications such as benzodiazepines, non-benzodiazepine hypnotics, and antihistamines. Over-the-counter remedies: Melatonin, valerian root, and other herbal supplements. Behavioral changes: Establishing a regular sleep schedule, avoiding screens before bedtime, and creating a relaxing bedtime routine. Devices: White noise machines, sleep masks, and weighted blankets can help create a more conducive sleep environment. It's important to use sleep aids with caution and under the guidance of a healthcare professional...
Read more

Pacemaker Market: Pacemaker to Play Major Role in $6,678.2 Million Economic Boost

A pacemaker is a small medical device that helps regulate an individual's heart rate. It is typically implanted under the skin of the chest or abdomen, and it sends electrical impulses to the heart to help it beat in a regular rhythm. Pacemakers are commonly used to treat various heart conditions that can cause an irregular or slow heartbeat, such as atrial fibrillation, heart block, or bradycardia. The device works by sensing the heart's electrical activity and sending electrical impulses to the heart muscle when necessary to keep it beating at a normal pace. The global pacemaker market size was valued at $4,667.2 million in 2020, and is projected to reach $6,678.2 million by 2030, registering a CAGR of 3.7% from 2021 to 2030. ♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-sample/1455 Pacemakers come in various types, depending on the specific needs of the patient. Some pacemakers are designed to res...
Read more